Metabolic consequences of adipose triglyceride lipase deficiency in humans: An in vivo study in patients with neutral lipid storage disease with Myopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages

  Natali, Andrea ^a   Gastaldelli, Amalia ^b   Camastra, Stefania ^a   Baldi, Simona ^a   Quagliarini, Fabiana ^c   Minicocci, Ilenia ^c   Bruno, Claudio ^d   Pennisi, Elena ^e   Arca, Marcello ^c  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TRIGLYCERIDE LIPASE; ADRENALIN; FATTY ACID; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADIPOSE TRIGLYCERIDE LIPASE DEFICIENCY; ADULT; ARTICLE; ATGL GENE; BODY COMPOSITION; BODY FAT; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY METABOLISM; ENZYME DEFICIENCY; FAT CONTENT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; GENE; GLUCOSE METABOLISM; HEART MUSCLE METABOLISM; HOMOZYGOSITY; HUMAN; IMPEDANCE; IN VIVO STUDY; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPIDOSIS; LIPOLYSIS; LIVER; LOSS OF FUNCTION MUTATION; MALE; MYOPATHY; NEUTRAL LIPID STORAGE DISEASE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREATIC STEATOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; STEATOSIS;

ADIPOSITY; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPASE; LIPID METABOLISM, INBORN ERRORS; LIPOLYSIS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION;

EID: 84883697425     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1444     Document Type: Article

References (39)

1. Greenberg AS, Coleman RA, Kraemer FB, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011;121:2102-2110.
2. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306:1383-1386.
3. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res. 2009;50:3-21.
4. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis: a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res. 2011;50:14-27.
5. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312:734-737.
6. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
7. Kienesberger PC, Lee D, Pulinilkunnil T, et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem. 2009;284:30218-30229.
8. Mairal A, Langin D, Arner P, Hoffstedt J. Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia. 2006;49: 1629-1636.
9. Rydén M, Jocken J, van Harmelen V, et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am J Physiol Endocrinol Metab. 2007; 292:E1847-E1855.
10. Fischer J, Lefevre C, Morava E, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007;39:28-30.
11. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab. 2009;297:E289-E296.
12. Ohkuma A, Noguchi S, Sugie H, et al. Clinical and genetic analysis of lipid storage myopathies. Muscle Nerve. 2009;39:333-342.
13. Reilich P, Horvath R, Krause S, et al. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. J Neurol. 2011;258:1987-1997.
14. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. Triglyceride deposit cardiomyovasculopathy. N Engl J Med. 2008;359:2396-2398.
15. Kobayashi K, Inoguchi T, Maeda Y, et al. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab. 2008;93:2877-2884.
16. Campagna F, Nanni L, Quagliarini F, et al. Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Biochem Biophys Res Commun. 2008;377:843-846.
17. Natali A, Muscelli E, Mari A, et al. Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. J Clin Endocrinol Metab. 2010;95:4703-4711.
18. Gastaldelli A, Coggan AR, Wolfe RR. Assessment of methods for improving tracer estimation of non-steady-state rate of appearance. J Appl Physiol. 1999;87:1813-1822.
19. Ma J, Slavens Z, Sun W, et al. Linear phase-error correction for improved water and fat separation in dual-echo dixon techniques. Magn Reson Med. 2008;60:1250-1255.
20. Sironi AM, Petz R, De Marchi D, et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med. 2012;29:622-627.
21. Fernandez M, Gastaldelli A, Triplitt C, et al. Metabolic effects of muraglitazar in type 2 diabetic subjects. Diabetes Obes Metab. 2011;13:893-902.
22. Le KA, Ventura EE, Fisher JQ, et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34:485-490.
23. Lang RM, Bierig M, Devereux RB, et al; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
24. Masci PG, Marinelli M, Piacenti M, et al. Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging. 2010;3:482-490.
25. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5:5845-5890.
26. Gastaldelli A, Natali A, Vettor R, Corradini SG. Insulin resistance, adipose depots and gut: Interactions and pathological implications. Dig Liver Dis. 2010;42:310-319.
27. Schweiger M, Schoiswohl G, Lass A, et al. The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem. 2008;283:17211-17220.
28. Fiorillo C, Brisca G, Cassandrini D, et al. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene. Biochem Biophys Res Commun. 2013;430:241-244.
29. Jocken JW, Smit E, Goossens GH, et al. Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific. Histochem Cell Biol. 2008;129:535-538.
30. Bobbioni-Harsch E, Pataky Z, Makoundou V, Kozakova M, Dekker J, Golay A. Fat distribution influences the cardio-metabolic profile in a clinically healthy European population. Eur J Clin Invest. 2009;39:1055-1064.
31. Wu JW, Wang SP, Alvarez F, et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology. 2011;54:122-132.
32. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.AmJ Physiol Endocrinol Metab. 2005;288:E462-E468.
33. Peyot ML, Guay C, Latour MG, et al. Adipose triglyceride lipase is implicated in fuel- and non-fuel-stimulated insulin secretion. J Biol Chem. 2009;284:16848-16859.
34. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207-258.
35. Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011;90:194-201.
36. Neglia D, De Caterina A, Marraccini P, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007;293:H3270-H3278.
37. Stefan N, Staiger H, Haring HU. Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase. Diabetologia. 2011;54:7-9.
38. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30:2916-2921.
39. Lin P, Li W, Wen B, et al. Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy. J Hum Genet. 2012;57:679-681.